Hello,
Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:
- The FDA authorized booster shots for the Moderna and Johnson & Johnson COVID-19 vaccines;
- Best Buy lays out its plan for entering the healthcare space;
- Dermatology startup Zerigo raised a $34 million Series B round to treat skin conditions with UV light.
If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it…
An employee (R) of Japan's Suntory Holdings receives the Moderna coronavirus vaccine for Covid-19.
KAZUHIRO NOGI/AFP via Getty Images
KAZUHIRO NOGI/AFP via Getty Images
The FDA just authorized booster shots of Moderna's and Johnson & Johnson's COVID-19 vaccines and is letting users mix and match shots
- The FDA authorized booster shots of the Moderna and J&J vaccines on Wednesday.
- The agency also authorized people to get different vaccine brand as a booster shot.
- J&J recipients can get a booster after two months. Moderna recipients should wait six months.
Check it out>>
Shoppers enter a Best Buy in New York.
Associated Press/Bebeto Matthews
Associated Press/Bebeto Matthews
A top Best Buy healthcare executive laid out how the retailer wants to help doctors care for patients in their homes
- Best Buy, known for selling electronics, is pushing deeper into healthcare.
- Best Buy Health President Deborah DiSanzo laid out its strategy at the HLTH conference in Boston.
- The retailer wants to help doctors care for patients at home through a new acquisition.
Get the full story>>
Zerigo makes a light-therapy device to treat skin conditions such as eczema.
ipopba/Getty Images
ipopba/Getty Images
See the 17-slide presentation that convinced Livongo's Glen Tullman to invest in a dermatology treatment startup
- Zerigo is a dermatology startup that treats conditions like psoriasis and eczema.
- It raised $43 million in Series B funding on Thursday led by Glen Tullman's 7wireVentures.
- Its smart device uses UVB light therapy to treat chronic dermatological conditions.
See the slides now>>
More stories we're reading:
- Pfizer says its booster shot has 95.6% efficacy against COVID-19 amid the Delta variant (Insider)
- A doctor developed a blood test for fibromyalgia. But did he tell the truth to his customers? (STAT)
- Blood tests that can detect cancer are about to hit the market. But experts are still waiting to see if they can upend deadly disease. (Insider)
- These doctors have been spreading COVID-19 vaccine misinformation for months (CNN)
- Pfizer's vaccine cuts the risk of COVID-19 hospitalization in teens by 93% in a CDC analysis (Insider)
-Leah
creditSource link
